IBO (Impact BioMedical) Ending Cash Position : $2.00 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Impact BioMedical Ending Cash Position?

Impact BioMedical's Ending Cash Position for the quarter that ended in Dec. 2024 was $2.00 Mil.

Impact BioMedical's quarterly Ending Cash Position increased from Jun. 2024 ($0.00 Mil) to Sep. 2024 ($2.67 Mil) but then declined from Sep. 2024 ($2.67 Mil) to Dec. 2024 ($2.00 Mil).

Impact BioMedical's annual Ending Cash Position declined from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil) but then increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($2.00 Mil).

Impact BioMedical Ending Cash Position Historical Data

The historical data trend for Impact BioMedical's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impact BioMedical Ending Cash Position Chart

Impact BioMedical Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

2.00

Impact BioMedical Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															-	-	-	2.67	2.00

Impact BioMedical Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Impact BioMedical's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.0010000000000003	+	1.998
	=	2.00

Impact BioMedical's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2.668	+	-0.669
	=	2.00

Impact BioMedical Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Impact BioMedical's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Impact BioMedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Impact BioMedical Inc (AMEX:IBO) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

1400 Broadfield Boulevard, Suite 130, Houston, TX, USA, 77084

Website

https://www.impactbiomedinc.com

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Impact BioMedical Headlines

From GuruFocus

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

By Marketwired • 09-16-2024